Form 4: Paysign EVP Joan Herman Executes Stock Sale
Statement of Changes in Beneficial Ownership
Paysign, Inc. EVP of Operations Joan M. Herman sold 6,667 shares of common stock pursuant to a Rule 10b5-1 trading plan.
Summary
- Joan M. Herman, EVP of Operations at Paysign, Inc., sold 6,667 shares of common stock.
- The transaction occurred on May 4, 2026, at a weighted average price of $7.0102 per share.
- Following the sale, the reporting person retains beneficial ownership of 831,583 shares.
- The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on September 12, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed through a pre-planned, automated trading program.
Positives
- The sale was conducted via a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.
Negatives
- The transaction represents a reduction in the direct equity stake held by a key member of the executive leadership team.
Risks
- Executive stock sales can sometimes be perceived negatively by the market as a signal of management's view on the company's future valuation.
Future Outlook
No specific forward-looking guidance regarding company performance was provided in this filing.
Management Comments
- The reporting person has committed to providing full details regarding the number of shares sold at each specific price within the reported range upon request.
Industry Context
StockSavvy.ai notes that executive stock sales under 10b5-1 plans are routine corporate governance events and generally do not reflect a change in company strategy or operational health.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate insiders to manage liquidity while maintaining compliance with SEC regulations.
Stakeholder Impact
- Minimal impact on shareholders as the sale was pre-planned and represents a small fraction of the executive's total holdings.
Next Steps
- No further actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2025-09-12 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-05-04 | Date of the stock sale transaction. |
| 2026-05-06 | Date the Form 4 was signed and filed. |
Keywords
Paysign, PAYS, Insider Trading, Form 4, Executive Compensation, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.